Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
258
-
Total 13F shares, excl. options
-
116M
-
Shares change
-
+78.6K
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
-$1.7M
-
Put/Call ratio
-
0.32
-
Number of buys
-
115
-
Number of sells
-
-114
-
Price
-
$16.07
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q2 2023
298 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q2 2023.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 116M shares
of 129M outstanding shares and own 89.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (20.8M shares), VANGUARD GROUP INC (14.6M shares), JANUS HENDERSON GROUP PLC (7.59M shares), BROWN ADVISORY INC (6.59M shares), T. Rowe Price Investment Management, Inc. (5.06M shares), STATE STREET CORP (4.93M shares), Greenhouse Funds LLLP (3.29M shares), DIMENSIONAL FUND ADVISORS LP (2.98M shares), First Light Asset Management, LLC (2.69M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.62M shares).
This table shows the top 258 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.